BHCM
ISEE

Boulder Hill Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Boulder Hill Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-18,200
Closed -$175K – 214
2022
Q2 		$175K Buy
+18,200
New +$228K 0.2% 88
2022
Q1 		– Sell
-20,800
Closed -$348K – 262
2021
Q4 		$348K Buy
+20,800
New +$341K 0.34% 113

Other funds holding ISEE

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Boulder Hill Capital Management's ISEE Position: Q3 2022 in Review

Boulder Hill Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2022, closing a stake of 18,200 shares — an estimated $175K sold.

Boulder Hill Capital Management first reported a position in ISEE in Q4 2021 and held it in 2 quarters. The position peaked at $348K in Q4 2021. 213 funds tracked by Wall St. Rank hold ISEE as of Q3 2022.

  • Boulder Hill Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Boulder Hill Capital Management sold 18,200 IVERIC bio, Inc. Common Stock shares in Q3 2022, an estimated $175K.
  • Boulder Hill Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Boulder Hill Capital Management's IVERIC bio, Inc. Common Stock position peaked at $348K in Q4 2021.
  • 213 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2022.

Based on Boulder Hill Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.